Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2214
https://www.valueinhealthjournal.com/article/S1098-3015(16)33580-X/fulltext
Title : Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33580-X&doi=10.1016/j.jval.2016.09.2214
First page : A733
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2100
Categories :
Tags :
Regions :
ViH Article Tags :